FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2231242 · Received September 1, 2011

Report

Report Number
2134265-2011-03632
Event Type
Injury
Date Received
September 1, 2011
Report Date
August 8, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

EVENT DATE - ON OR ABOUT (B)(6) 2007. DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

SAME CASE AS MFR#: 2134265-2011-03633 AND 2134265-2011-03623. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, A THROMBOSIS OCCURRED. IN (B)(6), 2006, THE PATIENT WAS ADMITTED TO THE TREATING FACILITY COMPLAINING OF CHEST PAIN AND ACUTE MYOCARDIAL INFARCTION. THE LESIONS BEING TREATED WERE LOCATED IN THE 70% STENOSED LEFT ANTERIOR DESCENDING (LAD) ARTERY, 80% STENOSED DIAGONAL (DX) ARTERY, AND 80% STENOSED MID RIGHT CORONARY ARTERY (RCA). THE LESIONS WERE SUCCESSFULLY TREATED WITH A 2.5X8MM TAXUS EXPRESS2 STENT (PROXIMAL), A 2.5X16MM TAXUS EXPRESS2 STENT, A 3.5X16MM TAXUS EXPRESS2 (MID LAD), AND A 3.5X20 TAXUS EXPRESS2 (MID RCA). ON OR ABOUT (B)(6) 2007, THE PATIENT PRESENTED WITH CHEST PAIN AND NAUSEA. THROMBOSIS WAS IDENTIFIED IN THE OVERLAPPING LAD AND DX STENTS. IT IS UNKNOWN HOW THE THROMBOSIS WAS TREATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK432

Patients

Seq Age Sex Outcome Treatment
1 Other